Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.

Pharmaceutical

Enalare Therapeutics

Enalare Therapeutics' headquarters in Princeton, NJ, United States

Daniel Motto

Joseph Pergolizzi

Jeanette Mathews

Frank Diana

Thomas Miller

Albert Dahan

David Battleman

Tj Gan

Gino Santini

Eugene Vortsman

Alexander Kraus

Joseph Petko

Bob Yedid

Mark Coleman

The Advisory Board at Enalare Therapeutics comprises a select group of experts who provide strategic guidance and scientific insight to advance the development of novel therapies for acute respiratory and critical care conditions. This team plays a crucial role in advising on clinical study designs, regulatory strategies, and broader scientific initiatives, ensuring that the company's innovative approaches align with best practices and the latest research advancements.

Advisory Board

The Leadership Team at Enalare Therapeutics drives the strategic direction and operational execution of the company. This team, comprised of executives from regulatory affairs, clinical development, and operations, collaborates to guide the development and commercialization of innovative therapies for acute respiratory conditions, ensuring compliance with regulatory standards and effective clinical trial implementation to advance their lead compound, ENA-001, towards pivotal studies.

Leadership Team

The Clinical Development and Regulatory Affairs team at Enalare Therapeutics is responsible for designing and executing clinical trials to assess the safety and efficacy of novel therapies, including ENA-001. This team collaborates closely with regulatory agencies to ensure compliance with industry standards, facilitates the submission of regulatory documents, and oversees the development of drug formulations, ultimately supporting the company's goal of advancing innovative treatments for acute respiratory conditions.

Enalare Therapeutics

Org chart

Board & advisors

Teams

Advisory Board

Leadership Team

Clinical Development and Regulatory Affairs

Offices

Enalare Therapeutics

Org chart

Board & advisors

Teams

Advisory Board

Leadership Team

Clinical Development and Regulatory Affairs

Offices

Related companies